48.00% -0.96

Galectin Therapeutics Inc (GALT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Galectin Therapeutics Inc Azioni (GALT) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	0.91% 9.648	9.561	9.166	9.003	10.34
Interest Income/Expense	24.20% 1.052	0.847	0.835	0.65	0.46
Operating Income/Loss	0.91% -9.648	-9.561	-9.166	-9.003	-10.34
Nonoperating Income/Loss	322.25% -1.841	-0.436	-1.262	-0.111	-1.185
Income/Loss From Continuing Operations Before Tax	14.92% -11.49	-9.997	-10.43	-9.114	-11.53
Income/Loss From Continuing Operations After Tax	14.92% -11.49	-9.997	-10.43	-9.114	-11.53
Net Income/Loss	14.92% -11.49	-9.997	-10.43	-9.114	-11.53
Preferred Stock Dividends And Other Adjustments	87.30% 0.008	0.063	-0.006	0.063	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	10,792% 61.98	0.569	59.70	59.58	59.48
Diluted Average Shares	10,792% 61.98	0.569	59.70	59.58	59.48
Basic Earnings Per Share	18.75% -0.19	-0.16	-0.24	-0.15	-0.19
Diluted Earnings Per Share	18.75% -0.19	-0.16	-0.24	-0.15	-0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	87.30% 0.008	0.063	-0.006	0.063	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%